Review



murine normal hepatocyte fl83b  (BioResource International Inc)

 
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
    • 90
      Buy from Supplier

    Structured Review

    BioResource International Inc murine normal hepatocyte fl83b
    Cytotoxicity of PG/Dox against normal cells. <t>FL83B,</t> HK-2, and h9c2 cells were sequentially treated with PG/Dox for 12 and 24 h, respectively, and cell viability was measured by MTT assay. Data were represented with mean ± SD from four independent experiments. Columns significantly different letter ( p < 0.05 ) to each other would be labeled with different letters
    Murine Normal Hepatocyte Fl83b, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine normal hepatocyte fl83b/product/BioResource International Inc
    Average 90 stars, based on 1 article reviews
    murine normal hepatocyte fl83b - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Doxorubicin metabolism moderately attributes to putative toxicity in prodigiosin/doxorubicin synergism in vitro cells"

    Article Title: Doxorubicin metabolism moderately attributes to putative toxicity in prodigiosin/doxorubicin synergism in vitro cells

    Journal: Molecular and Cellular Biochemistry

    doi: 10.1007/s11010-020-03864-x

    Cytotoxicity of PG/Dox against normal cells. FL83B, HK-2, and h9c2 cells were sequentially treated with PG/Dox for 12 and 24 h, respectively, and cell viability was measured by MTT assay. Data were represented with mean ± SD from four independent experiments. Columns significantly different letter ( p < 0.05 ) to each other would be labeled with different letters
    Figure Legend Snippet: Cytotoxicity of PG/Dox against normal cells. FL83B, HK-2, and h9c2 cells were sequentially treated with PG/Dox for 12 and 24 h, respectively, and cell viability was measured by MTT assay. Data were represented with mean ± SD from four independent experiments. Columns significantly different letter ( p < 0.05 ) to each other would be labeled with different letters

    Techniques Used: MTT Assay, Labeling

    Cytotoxic alteration of PG/Dox by addition of autophagic inhibitors in normal cells. FL83B, HK-2, and h9c2 cells were treated with PG coupled with 3-methyladenine (3MA) or bafilomycin A1 (BA1) for 12 h following by Dox for 12 h, respectively. Results were normalized with untreated control and shown in mean ± SD from four independent experiments. “*” and “#” were represented to significantly different with untreated control and PG/Dox alone, respectively
    Figure Legend Snippet: Cytotoxic alteration of PG/Dox by addition of autophagic inhibitors in normal cells. FL83B, HK-2, and h9c2 cells were treated with PG coupled with 3-methyladenine (3MA) or bafilomycin A1 (BA1) for 12 h following by Dox for 12 h, respectively. Results were normalized with untreated control and shown in mean ± SD from four independent experiments. “*” and “#” were represented to significantly different with untreated control and PG/Dox alone, respectively

    Techniques Used: Control

    Cell cycle change in normal cells after PG/Dox treatment. FL83B, HK-2, and h9c2 were treated with PG and Dox, respectively, stained with PI, and determined intracellular fluorescent intensity by flow cytometry. Data were summarized from three independent experiments and shown in mean ± SD which were marked with “*” or “#” as significantly different ( p < 0.05 ) with untreated control or Dox alone
    Figure Legend Snippet: Cell cycle change in normal cells after PG/Dox treatment. FL83B, HK-2, and h9c2 were treated with PG and Dox, respectively, stained with PI, and determined intracellular fluorescent intensity by flow cytometry. Data were summarized from three independent experiments and shown in mean ± SD which were marked with “*” or “#” as significantly different ( p < 0.05 ) with untreated control or Dox alone

    Techniques Used: Staining, Flow Cytometry, Control



    Similar Products

    murine normal hepatocyte fl83b  (BioResource International Inc)
    90
    BioResource International Inc murine normal hepatocyte fl83b
    Cytotoxicity of PG/Dox against normal cells. <t>FL83B,</t> HK-2, and h9c2 cells were sequentially treated with PG/Dox for 12 and 24 h, respectively, and cell viability was measured by MTT assay. Data were represented with mean ± SD from four independent experiments. Columns significantly different letter ( p < 0.05 ) to each other would be labeled with different letters
    Murine Normal Hepatocyte Fl83b, supplied by BioResource International Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/murine normal hepatocyte fl83b/product/BioResource International Inc
    Average 90 stars, based on 1 article reviews
    murine normal hepatocyte fl83b - by Bioz Stars, 2026-03
    90/100 stars
    		  Buy from Supplier

    Image Search Results


    Cytotoxicity of PG/Dox against normal cells. FL83B, HK-2, and h9c2 cells were sequentially treated with PG/Dox for 12 and 24 h, respectively, and cell viability was measured by MTT assay. Data were represented with mean ± SD from four independent experiments. Columns significantly different letter ( p < 0.05 ) to each other would be labeled with different letters

    Journal: Molecular and Cellular Biochemistry

    Article Title: Doxorubicin metabolism moderately attributes to putative toxicity in prodigiosin/doxorubicin synergism in vitro cells

    doi: 10.1007/s11010-020-03864-x

    Figure Lengend Snippet: Cytotoxicity of PG/Dox against normal cells. FL83B, HK-2, and h9c2 cells were sequentially treated with PG/Dox for 12 and 24 h, respectively, and cell viability was measured by MTT assay. Data were represented with mean ± SD from four independent experiments. Columns significantly different letter ( p < 0.05 ) to each other would be labeled with different letters

    Article Snippet: A total of 3 cell lines were from different sources: murine normal hepatocyte FL83B and cardio-myoblast h9c2 from Bioresource Collection and Research Center (BCRC, Hsinchu, Taiwan), and human renal cortex/proximal tubule epithelial cell HK-2 from Prof. Yaw-Syan Fu (Department of Biomedical Science and Environment Biology, Kaohsiung Medical University, Kaohsiung, Taiwan) were applied to test the hypothesis in this study.

    Techniques: MTT Assay, Labeling

    Cytotoxic alteration of PG/Dox by addition of autophagic inhibitors in normal cells. FL83B, HK-2, and h9c2 cells were treated with PG coupled with 3-methyladenine (3MA) or bafilomycin A1 (BA1) for 12 h following by Dox for 12 h, respectively. Results were normalized with untreated control and shown in mean ± SD from four independent experiments. “*” and “#” were represented to significantly different with untreated control and PG/Dox alone, respectively

    Journal: Molecular and Cellular Biochemistry

    Article Title: Doxorubicin metabolism moderately attributes to putative toxicity in prodigiosin/doxorubicin synergism in vitro cells

    doi: 10.1007/s11010-020-03864-x

    Figure Lengend Snippet: Cytotoxic alteration of PG/Dox by addition of autophagic inhibitors in normal cells. FL83B, HK-2, and h9c2 cells were treated with PG coupled with 3-methyladenine (3MA) or bafilomycin A1 (BA1) for 12 h following by Dox for 12 h, respectively. Results were normalized with untreated control and shown in mean ± SD from four independent experiments. “*” and “#” were represented to significantly different with untreated control and PG/Dox alone, respectively

    Article Snippet: A total of 3 cell lines were from different sources: murine normal hepatocyte FL83B and cardio-myoblast h9c2 from Bioresource Collection and Research Center (BCRC, Hsinchu, Taiwan), and human renal cortex/proximal tubule epithelial cell HK-2 from Prof. Yaw-Syan Fu (Department of Biomedical Science and Environment Biology, Kaohsiung Medical University, Kaohsiung, Taiwan) were applied to test the hypothesis in this study.

    Techniques: Control

    Cell cycle change in normal cells after PG/Dox treatment. FL83B, HK-2, and h9c2 were treated with PG and Dox, respectively, stained with PI, and determined intracellular fluorescent intensity by flow cytometry. Data were summarized from three independent experiments and shown in mean ± SD which were marked with “*” or “#” as significantly different ( p < 0.05 ) with untreated control or Dox alone

    Journal: Molecular and Cellular Biochemistry

    Article Title: Doxorubicin metabolism moderately attributes to putative toxicity in prodigiosin/doxorubicin synergism in vitro cells

    doi: 10.1007/s11010-020-03864-x

    Figure Lengend Snippet: Cell cycle change in normal cells after PG/Dox treatment. FL83B, HK-2, and h9c2 were treated with PG and Dox, respectively, stained with PI, and determined intracellular fluorescent intensity by flow cytometry. Data were summarized from three independent experiments and shown in mean ± SD which were marked with “*” or “#” as significantly different ( p < 0.05 ) with untreated control or Dox alone

    Article Snippet: A total of 3 cell lines were from different sources: murine normal hepatocyte FL83B and cardio-myoblast h9c2 from Bioresource Collection and Research Center (BCRC, Hsinchu, Taiwan), and human renal cortex/proximal tubule epithelial cell HK-2 from Prof. Yaw-Syan Fu (Department of Biomedical Science and Environment Biology, Kaohsiung Medical University, Kaohsiung, Taiwan) were applied to test the hypothesis in this study.

    Techniques: Staining, Flow Cytometry, Control